Abstract:Prion diseases, also known as transmissible spongiform encephalopathies (TSEs), are a group of fatal neurodegenerative disorders infecting both humans and animals. Recent works have demonstrated that the soluble prion protein oligomer (PrPO), the intermediate of the conformational transformation from the host-derived cellular form (PrPC) to the disease-associated Scrapie form (PrPSc), exerts the major neurotoxicity in vitro and in vivo. Rabbits show strong resistance to TSEs, the underlying mechanism is unclear to date. It is expected that the relative TSEs-resistance of rabbits is closely associated with the unique properties of rabbit prion protein oligomer which remain to be addressed in detail. In the present work, we prepared rabbit prion protein oligomer (recRaPrPO) and human prion protein oligomer (recHuPrPO) under varied conditions, analyzed the effects of pH, NaCl concentration and incubation temperature on the oligomerization, and compared the properties of recRaPrPO and recHuPrPO. We found that several factors facilitated the formation of prion protein oligomers, including low pH, high NaCl concentration, high incubation temperature and low conformational stability of monomeric prion protein. RecRaPrPO was formed more slowly than recHuPrPO at physiological-like conditions (< 57°C, < 150 mM NaCl). Furthermore, recRaPrPO possessed higher susceptibility to proteinase K and lower cytotoxicity in vitro than recHuPrPO. These unique properties of recRaPrPO might substantially contribute to the TSEs-resistance of rabbits. Our work sheds light on the oligomerization of prion proteins and is of benefit to mechanistic understanding of TSEs-resistance of rabbits.

Physico-Chemical Property and Polyclonal Antibody Production of Bovine Prion Protein

Synthesizing and Immunization Analysis of Bovine PrPc Structural Protein Peptides

High-level Expression and Secondary Structure Analysis of the Bovine Mature Prion Protein

Preparations of Specific Antibodies Against PrP N-terminal or C-terminal Peptides and Preliminary Study on Establishment of ELISA Diagnostic Method

Expression of a Chimera of Bovine Prion Protein and Yeast Ure2p Prion Domain in Escherichia Coli and Preparation of Monoclonal Antibodies Against Prion Protein

Effect of the Thermodynamic Factor on Conformational Conversion of the Ovine Prion Protein in Vitro

Prokaryotic Expression of Human Apolipoprotein E and Analyses of the Molecular Interaction Between ApoE and PrP Proteins in Vitro

Cloning Prokaryotic Expression and Purification of Prion PrP~C51-216 from Ovis Aries

Generation of Genetic Engineering Monoclonal Antibodies Against Prion Protein

Simple Method of Monoclonal Antibody Production Against Mammalian Cellular Prion Protein

Preparation of Monoclonal Antibodies Against Prion Proteins with Full-Length Hamster PrP.

Bovine PrPC directly interacts with αB-crystalline

[Analysis of Monoclonal Antibody Binding Sites in Ovine Prion Protein].

Expression and purification of human PrP-like protein Shadoo and preparation of antibody against Shadoo

Purification of Recombinant Bovine Normal Prion Protein PrP(104–242) by HPHIC

Recombinant Neural Protein PrP Can Bind with Both Recombinant and Native Apolipoprotein E in Vitro

Semi-synthesis of murine prion protein by native chemical ligation and chemical activation for preparation of polypeptide-α-thioester.

Capillary Isoelectric Focusing and Affinity Capillary Electrophoresis Approaches for the Determination of Binding Constants for Antibodies to the Prion Protein

Fibril Formation of the Rabbit/Human/Bovine Prion Proteins

Generation and Identification of Phage Engineering Antibodies Library Against Hamster Prion Protein

Unique Properties of the Rabbit Prion Protein Oligomer.